RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Clayton Yates to Female

This is a "connection" page, showing publications Clayton Yates has written about Female.
Connection Strength

0.324
  1. Angajala A, Raymond H, Muhammad A, Uddin Ahmed MS, Haleema S, Haque M, Wang H, Campbell M, Martini R, Karanam B, Kahn AG, Bedi D, Davis M, Tan M, Dean-Colomb W, Yates C. MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans. Sci Rep. 2022 12 22; 12(1):22178.
    View in: PubMed
    Score: 0.056
  2. Davis M, Tripathi S, Hughley R, He Q, Bae S, Karanam B, Martini R, Newman L, Colomb W, Grizzle W, Yates C. AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature. PLoS One. 2018; 13(6):e0196909.
    View in: PubMed
    Score: 0.041
  3. Jones J, Mukherjee A, Karanam B, Davis M, Jaynes J, Reams RR, Dean-Colomb W, Yates C. African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression. Cancer Lett. 2016 10 01; 380(2):513-522.
    View in: PubMed
    Score: 0.036
  4. Jones J, Wang H, Karanam B, Theodore S, Dean-Colomb W, Welch DR, Grizzle W, Yates C. Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clin Exp Metastasis. 2014 Jun; 31(5):497-510.
    View in: PubMed
    Score: 0.030
  5. Yates C, Shepard CR, Papworth G, Dash A, Beer Stolz D, Tannenbaum S, Griffith L, Wells A. Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Adv Cancer Res. 2007; 97:225-46.
    View in: PubMed
    Score: 0.018
  6. Muhammad A, Hixon JC, Pharmacy Yusuf A, Rivas Zarete JI, Johnson I, Miller J, Adu-Addai B, Yates C, Mahavadi S. Sex-specific epigenetics drive low GPER expression in gastrointestinal smooth muscles in type 2 diabetic mice. Sci Rep. 2024 03 07; 14(1):5633.
    View in: PubMed
    Score: 0.015
  7. Singhal SK, Byun JS, Yan T, Yancey R, Caban A, Gil Hernandez S, Bufford S, Hewitt SM, Winfield J, Pradhan J, Mustkov V, McDonald JA, P?rez-Stable EJ, N?poles AM, Vohra N, De Siervi A, Yates C, Davis MB, Yang M, Tsai YC, Weissman AM, Gardner K. Protein expression of the gp78 E3 ligase predicts poor breast cancer outcome based on race. JCI Insight. 2022 07 08; 7(13).
    View in: PubMed
    Score: 0.014
  8. Martini R, Chen Y, Jenkins BD, Elhussin IA, Cheng E, Hoda SA, Ginter PS, Hanover J, Zeidan RB, Oppong JK, Adjei EK, Jibril A, Chitale D, Bensenhaver JM, Awuah B, Bekele M, Abebe E, Kyei I, Aitpillah FS, Adinku MO, Ankomah K, Osei-Bonsu EB, Nathansan SD, Jackson L, Jiagge E, Petersen LF, Proctor E, Nikolinakos P, Gyan KK, Yates C, Kittles R, Newman LA, Davis MB. Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort. Sci Rep. 2021 04 29; 11(1):9247.
    View in: PubMed
    Score: 0.012
  9. Davenport ML, Echols JB, Silva AD, Anderson JC, Owens P, Yates C, Wei Q, Harada S, Hurst DR, Edmonds MD. miR-31 Displays Subtype Specificity in Lung Cancer. Cancer Res. 2021 04 15; 81(8):1942-1953.
    View in: PubMed
    Score: 0.012
  10. Singhal SK, Byun JS, Park S, Yan T, Yancey R, Caban A, Hernandez SG, Hewitt SM, Boisvert H, Hennek S, Bobrow M, Ahmed MSU, White J, Yates C, Aukerman A, Vanguri R, Bareja R, Lenci R, Farr? PL, De Siervi A, N?poles AM, Vohra N, Gardner K. Kaiso (ZBTB33) subcellular partitioning functionally links LC3A/B, the tumor microenvironment, and breast cancer survival. Commun Biol. 2021 02 01; 4(1):150.
    View in: PubMed
    Score: 0.012
  11. Locke JE, Reed RD, Kumar V, Berry B, Hendricks D, Carter A, Shelton BA, Mustian MN, MacLennan PA, Qu H, Hannon L, Yates C, Hanaway MJ. Enhanced Advocacy and Health Systems Training Through Patient Navigation Increases Access to Living-donor Kidney Transplantation. Transplantation. 2020 01; 104(1):122-129.
    View in: PubMed
    Score: 0.011
  12. Reed RD, Hites L, Mustian MN, Shelton BA, Hendricks D, Berry B, MacLennan PA, Blackburn J, Wingate MS, Yates C, Hannon L, Kilgore ML, Locke JE. A Qualitative Assessment of the Living Donor Navigator Program to Identify Core Competencies and Promising Practices for Implementation. Prog Transplant. 2020 03; 30(1):29-37.
    View in: PubMed
    Score: 0.011
  13. Ntiamoah P, Monu NR, Abdulkareem FB, Adeniji KA, Obafunwa JO, Komolafe AO, Yates C, Kaninjing E, Carpten JD, Salhia B, Odedina FT, Edelweiss M, Kingham TP, Alatise OI. Pathology Services in Nigeria: Cross-Sectional Survey Results From Three Cancer Consortia. J Glob Oncol. 2019 09; 5:1-9.
    View in: PubMed
    Score: 0.011
  14. Jenkins BD, Martini RN, Hire R, Brown A, Bennett B, Brown I, Howerth EW, Egan M, Hodgson J, Yates C, Kittles R, Chitale D, Ali H, Nathanson D, Nikolinakos P, Newman L, Monteil M, Davis MB. Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry. Cancer Epidemiol Biomarkers Prev. 2019 04; 28(4):690-700.
    View in: PubMed
    Score: 0.011
  15. Henderson HJ, Karanam B, Samant R, Vig K, Singh SR, Yates C, Bedi D. Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival. PLoS One. 2017; 12(12):e0189662.
    View in: PubMed
    Score: 0.010
  16. Arora R, Schmitt D, Karanam B, Tan M, Yates C, Dean-Colomb W. Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers. Oncotarget. 2015 Jan 20; 6(2):662-78.
    View in: PubMed
    Score: 0.008
  17. Smith BN, Burton LJ, Henderson V, Randle DD, Morton DJ, Smith BA, Taliaferro-Smith L, Nagappan P, Yates C, Zayzafoon M, Chung LW, Odero-Marah VA. Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2. PLoS One. 2014; 9(8):e104987.
    View in: PubMed
    Score: 0.008
  18. Arora R, Yates C, Gary BD, McClellan S, Tan M, Xi Y, Reed E, Piazza GA, Owen LB, Dean-Colomb W. Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer. PLoS One. 2014; 9(6):e98370.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support